Stay updated on Cabotegravir vs TDF/FTC in Women Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.

Latest updates to the Cabotegravir vs TDF/FTC in Women Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.5.2 deployed, replacing v3.5.0. This update appears to be an internal version change with no visible changes to the study details page content.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check41 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check48 days agoChange DetectedThe site revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.4.2 is now shown on the site, and the prior notice about government funding lapse as well as the previous Revision: v3.4.1 entry have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check84 days agoChange DetectedAdded a site-wide notice about a lapse in government funding that may affect data updates and updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check91 days agoChange DetectedShow glossary option added and footer/metadata labels updated (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0) replacing older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). No changes to the core study content or user-facing study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Cabotegravir vs TDF/FTC in Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.